Opening question: When a research-peptide listing flashes a PeptideMass output, a “theoretical peptide masses” table, or a claim that a product is “mass-fingerprint matched,” how do you tell a cleavage-mass calculator from proof that a vial is cleared for people?
Short answer: open the ExPASy PeptideMass tool and the PeptideMass documentation. PeptideMass is peptide-characterisation software on the Expasy server designed to calculate the theoretical masses of peptides generated by chemical or enzymatic cleavage of proteins, to assist in interpreting peptide mass fingerprinting and peptide-mapping experiments. Sequences can be entered by the user or taken from UniProtKB. That is mass-spectrometry planning literacy—not a medicines review of a catalog SKU.
A practical PeptideMass checklist when ads lean on mass tables:
- What the documentation says it is for: PeptideMass helps researchers predict which peptide masses should appear after a chosen cleavage so they can interpret fingerprinting and mapping results. A theoretical mass list is a lab calculation aid, not a pharmacy clearance stamp for a research-only listing.
- UniProt annotations can adjust expected masses: When a UniProtKB/Swiss-Prot entry is used, the program can consider database annotations—including many post-translational modifications that affect peptide masses—and warn about peptides unlikely to be found in fingerprinting. Those are research annotations about known proteins, not human-use approval of a nearby vial.
- Enzyme/chemical cleavage choices stay experimental design: Choosing trypsin or another cleavage chemistry changes which theoretical peptides appear. Matching an ad’s mass table to a cleavage rule does not prove the SKU was manufactured, tested, or authorized as a medicine.
- Distinct from spectral libraries and deposit IDs: PeptideMass predicts masses from sequence and cleavage rules. It is not the same as browsing a measured peptide spectral library, a ProteomeXchange dataset badge, or a Universal Spectrum Identifier. Keep theoretical calculators separate from deposited experimental evidence—and keep both separate from product clearance.
- What to open next: If an ad implies a research peptide is “PeptideMass-confirmed,” open the tool and documentation and ask whether the claim is about fingerprinting literacy—or about decorating merchandise with a familiar Expasy screenshot.
None of those steps turns a laboratory research listing into an approved medicine. Company research-only catalogs document laboratory intent and paperwork such as certificates of analysis; they do not create human-use approval. For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use, and describes third-party testing with certificates of analysis.
Bottom line: Use PeptideMass to understand how researchers generate theoretical peptide masses for mapping experiments, then ask whether the ad is teaching that distinction or implying a research peptide is medically meaningful because a mass table looks official. That habit changes what you notice in catalogs—it is not advice to buy, inject, or dose any peptide.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against ExPASy PeptideMass home and documentation (fetched 2026-09-30 PT). No invented studies, quotes, or dosing. Not medical or legal advice.
Sources
1. ExPASy PeptideMass (tool home)
2. ExPASy PeptideMass — Documentation
3. Apollo Peptides (company facts only)
Related reading
What NIST peptide mass spectral libraries mean when ads say “MS-matched”
How to read PeptideAtlas when ads say MS-confirmed
How to read ProteomeXchange when peptide ads flash PXD dataset badges